Coronary Revascularization in Patients On Dialysis in China-Retrospective Registry (CRUISE-R)

China-Japan Friendship Hospital

Status: Active, not recruiting

Conditions: Coronary Artery Disease; Dialysis; End Stage Renal Disease

Study type: Observational

Funder types: Other

Identifiers

NCT05841082

CRUISE-2020-12-28

Details and patient eligibility

About

Coronary artery disease (CAD) is the leading cause of death in end-stage renal disease (ESRD) patients requiring dialysis. There are limited data on clinical characteristics, treatment strategies and outcomes in this special patient population in China. As a nationwide, observational, multicenter cohort study, this study consecutively included ESRD patients on dialysis with significant CAD at 30 tertiary care centers in 12 provinces in China from January 2015 to June 2021. Patient data collected included demographics, comorbidities, cardiac history, cardiac function, location and severity of CAD, procedural information, medications, and clinical events.

Enrollment: 1,249 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 50% or greater stenosis in any of three main coronary arteries or left main coronary artery on visual assessment of the coronary angiogram
• Receive peritoneal dialysis or hemodialysis for more than 3 months

Exclusion criteria

Trial design

1,249 participants in 1 patient group

CAD

Description:

The investigators recruited all consecutive end-stage renal disease patients requiring dialysis who had significant coronary artery disease, defined as 50% or greater stenosis in any of three main coronary arteries or left main coronary artery on visual assessment of the coronary angiogram